High-Resolution Ultrasound SIU Academy®. Lughezzani G. 05/22/21; 315668 Topic: Active surveillance
Rafael Sanchez-Salas, MD, presented “Urologic Perspective on the Clinical Utility of and Emerging Data on Micro-Ultrasound” during the virtual 5th Global Summit on Precision Diagnosis and Treatment of Prostate Cancer in September 2021.
In part 1 of a 2-part series on micro-ultrasound for prostate cancer imaging, Sangeet Ghai, MD, FRCR, Deputy Chief of Research and Associate Professor in the Joint Department of Medical Imaging (JDMI) at the University of Toronto in Ontario, Canada
Gerald L. Andriole, Jr., MD, Robert K. Royce Distinguished Professor and Chief of Urologic Surgery at Barnes-Jewish Hospital, the Siteman Cancer Center, and Washington University School of Medicine in St. Louis, Missouri, introduces the OPTIMUM trial
Gerald L. Andriole, Jr., MD, presented “Considerations to Improve Screening for Prostate Cancer” for the Grand Rounds in Urology audience in December 2021.
Missed our webinar on ExactVu micro-ultrasound prostate biopsy? Now you can review this recorded version anytime. While you won't be able to participate live, feel free to pass along questions or comments to Brian at bwodlinger@exactimaging.com
Priya N. Werahera, PhD, Research Assistant Professor in the Departments of Pathology and Bioengineering at the University of Colorado Anschutz Medical Campus, shares results from a study that compared ExactVu™ Micro-Ultrasound’s accuracy with that of mapping biopsy’s.
Neal D. Shore, MD, FACS, Medical Director for the Carolina Urologic Research Center, discusses the evolution of transrectal (TR) versus transperineal (TP) prostate biopsy, and compares the efficacy of multi-parametric MRI (mpMRI) versus next generation micro-ultrasound.
Neal D. Shore, MD, presented “29 MHz High Resolution Micro-Ultrasound: Improving Real-Time Targeting of Prostate Biopsies” during the 29th Annual International Prostate Cancer Update on January 26, 2019 in Beaver Creek, Colorado.
Ryan S. Hsi, MD, reviews findings from abstracts presented at the American Urological Association’s 2019 Annual Meeting on the use of high-resolution microultrasound in detecting prostate cancer. The research suggests that 18F-fluciclovine PET is most useful in patients with high PSA and can potentially guide lymph node dissection during surgery, while PSMA gallium PET appears to have promise.
Laurence Klotz, MD, discusses the limitations of multiparametric MRI (mpMRI) targeted prostate biopsy, especially in the active surveillance setting, and how a novel 29 MHz high resolution micro-ultrasound technology could be an improved alternative.
E. David Crawford, MD, discusses the wide range of clinical possibilities related to prostate cancer imaging with a novel 29 MHz micro-ultrasound technology. He specifically deliberates the possibility of micro-ultrasound to improve screening pathways and focal therapy protocols.
Dr. Neal Shore, past president of the Large Urology Group Practice Association (LUGPA) discusses ExactVu micro-ultrasound and what it does for his practice.
Dr. Neal Shore, of Atlantic Urology in Myrtle Beach, discusses how micro-ultrasound can make Active Surveillance better.
CEO of Arkansas Urology, E. Scot Davis, discusses micro-ultrasound for Urologists and other Administrators
Dr. Gregg Eure discusses the benefits of micro-ultrasound for his urology practice.
Dr. Neal Shore discusses the clinical, patient and urologist-based benefits of ExactVu high resolution micro-ultrasound system for targeted real-time prostate biopsies #targetedprostatebiopsy @GRUrology #Microultrasound
Dr. Lughezzani at EMUC 2018 - Diagnostic Accuracy of Targeted Prostate Biopsies
Laurence Klotz, MD, discusses the limitations of multiparametric MRI (mpMRI) targeted prostate biopsy, especially in the active surveillance setting, and how a novel 29 MHz high resolution micro-ultrasound technology could be an improved alternative. Additionally, he describes his experience with this technology at his institution.
E. David Crawford, MD, discusses the wide range of clinical possibilities related to prostate cancer imaging with a novel 29 MHz micro-ultrasound technology. He specifically deliberates the possibility of micro-ultrasound to improve screening pathways and focal therapy protocols.
Dr. Bruce Rosenfeld discusses Micro-Ultrasound early results with 29MHz ExactVu Micro-Ultrasound at the SIU 2017 meeting in Lisbon, Portugal.
Experts Dr. Jochen Walz (urologist) and Dr. Jurgen Fütterer (radiologist) are hosting a webinar on fusion biopsy: To Fuse or Not to Fuse? The webinar will discuss several aspects of the MRI-based prostate cancer diagnostic pathway; address advantages and limitations of MRI; and examine the advantages and disadvantages of the cognitive and the MRI-ultrasound fusion approaches.
Dr. Jochen Walz, IPC Marseilles and past president of the European Section of Urological Imaging, discusses ExactVu micro-ultrasound in Bilbao.